AstraZeneca India gets CDSCO approval for additional indication for Osimertinib in unresectable… EP News Bureau May 29, 2025 The approval follows evidence from the Phase III LAURA trial, which demonstrated significant clinical benefits in delaying disease…
MRP of 3 anti-cancer drugs to come down due to exemption from custom duty and reduction in GST EP News Bureau Oct 29, 2024 NPPA has issued an OM directing the concerned manufacturers to reduce the maximum retail price on Trastuzumab, Osimertinib and…
Decoding Budget 2024-25: A lacklustre budget for pharma EP News Bureau Jul 23, 2024 The Finance Minister announced the Budget for 2024-25 on July 23, during the Monsoon Session of Parliament
